Clinical Trials for Provenance Biopharmaceuticals

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Provenance Biopharmaceuticals

Clinical Trials (1)

NCT03958383
IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma
PHASE1/PHASE2Active, not recruiting
8 participants
Started: Jan 30, 2020 · Completed: Aug 15, 2026
1 condition5 sponsors1 location